Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinoma-Reference-Cited by-同舟云学术

Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinoma

Published:2024-01 Issue:1 Volume:10 Page:e23521
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Lee Jung Hyun^ORCID,Lee Justin Daho,Paulson Kelly,Voillet Valentin,Berndt Andre^ORCID,Church Candice,Lachance Kristina,Park Song Y.^ORCID,Yamamoto Naomi K.,Cromwell Elizabeth A.^ORCID,Gottardo Raphael,Chapuis Aude G.,Nghiem Paul

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference79 articles.

1. Merkel cell carcinoma;Becker;Nat. Rev. Dis. Prim.,2017

2. Burden of disease, early diagnosis, and treatment of Merkel cell carcinoma in Latin America;Schmerling;J. Glob. Oncol.,2018

3. Merkel cell carcinoma in the age of immunotherapy: facts and hopes;Colunga;Clin. Cancer Res.,2018

4. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA;Paulson;Nat. Commun.,2018

5. Application of PD-1 blockade in cancer immunotherapy;Wu;Comput. Struct. Biotechnol. J.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models;Frontiers in Oncology;2024-07-29

2. Syringocystadenocarcinoma papilliferum: a systematic review of clinical characteristics, reappraisal of associations, diagnostic pitfalls and management challenges;Archives of Dermatological Research;2024-06-21

3. Targeted Gene Therapy: Promises and Challenges in Disease Management;Journal of Bio-X Research;2024-01